Tags

Type your tag names separated by a space and hit enter

CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
Lung Cancer. 2008 Oct; 62(1):15-22.LC

Abstract

CpG island methylator phenotype (CIMP) involving methylation abnormalities of tumor suppressor gene (TSG) on short arm of chromosome 3 (chromosome 3p) has not been so far epigenetically elucidated in non-small cell lung cancer (NSCLC). Using methylation-specific PCR (MSP) method, we examined methylation profiles for eight TSGs harbored in chromosome 3p in 60 NSCLC tissues and 60 paired normal tissues as well as 11 normal blood samples. CIMP positive is referred to having four or more than four synchronously methylated genes per sample. Consequently, 59 of 60 (98.3%) NSCLC presented promoter methylation of at least one gene while only one malignant tumor showed no methylation of any of eight genes. The frequency of promoter methylation for eight genes explored ranged from 12% for hMLH1 to 67% for RASSF1A given that of VHL (none) was not considered. Interestingly, CIMP+ was found in 56.7% (34/60) of NSCLC, and in 6.7% (4/60) of paired normal tissues and 0% (0/11) of normal blood samples, respectively; CIMP- was present in 43.3% (26/60) of NSCLC, 93.3% (56/60) of paired normal tissues, and 100% (11/11) of normal blood samples, respectively. The data suggest that CIMP status was significantly associated with NSCLC, paired normal tissues and normal blood samples (P<0.001). In addition, there appeared to be a significant association between CIMP status and survival prognosis of NSCLC (P=0.0166). In the present study, for the first time, we shed light on the presence of chromosome 3p-specific CIMP, which might play an important role in tumorigenesis of NSCLC.

Authors+Show Affiliations

Laboratory of Medical Genetics, School of Basic Medicine & Biological Sciences, Suzhou University, 199 Ren'ai Road, Sino-Singapore Industrial Park, 215123 Suzhou, PR China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

18358560

Citation

Liu, Zeyi, et al. "CpG Island Methylator Phenotype Involving Tumor Suppressor Genes Located On Chromosome 3p in Non-small Cell Lung Cancer." Lung Cancer (Amsterdam, Netherlands), vol. 62, no. 1, 2008, pp. 15-22.
Liu Z, Zhao J, Chen XF, et al. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Lung Cancer. 2008;62(1):15-22.
Liu, Z., Zhao, J., Chen, X. F., Li, W., Liu, R., Lei, Z., Liu, X., Peng, X., Xu, K., Chen, J., Liu, H., Zhou, Q. H., & Zhang, H. T. (2008). CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands), 62(1), 15-22. https://doi.org/10.1016/j.lungcan.2008.02.005
Liu Z, et al. CpG Island Methylator Phenotype Involving Tumor Suppressor Genes Located On Chromosome 3p in Non-small Cell Lung Cancer. Lung Cancer. 2008;62(1):15-22. PubMed PMID: 18358560.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. AU - Liu,Zeyi, AU - Zhao,Jun, AU - Chen,Xiao-Feng, AU - Li,Wenwen, AU - Liu,Rengyun, AU - Lei,Zhe, AU - Liu,Xia, AU - Peng,Xiaobei, AU - Xu,Ke, AU - Chen,Jun, AU - Liu,Hongyu, AU - Zhou,Qing-Hua, AU - Zhang,Hong-Tao, Y1 - 2008/03/20/ PY - 2007/11/22/received PY - 2008/01/15/revised PY - 2008/02/05/accepted PY - 2008/3/25/pubmed PY - 2009/2/4/medline PY - 2008/3/25/entrez SP - 15 EP - 22 JF - Lung cancer (Amsterdam, Netherlands) JO - Lung Cancer VL - 62 IS - 1 N2 - CpG island methylator phenotype (CIMP) involving methylation abnormalities of tumor suppressor gene (TSG) on short arm of chromosome 3 (chromosome 3p) has not been so far epigenetically elucidated in non-small cell lung cancer (NSCLC). Using methylation-specific PCR (MSP) method, we examined methylation profiles for eight TSGs harbored in chromosome 3p in 60 NSCLC tissues and 60 paired normal tissues as well as 11 normal blood samples. CIMP positive is referred to having four or more than four synchronously methylated genes per sample. Consequently, 59 of 60 (98.3%) NSCLC presented promoter methylation of at least one gene while only one malignant tumor showed no methylation of any of eight genes. The frequency of promoter methylation for eight genes explored ranged from 12% for hMLH1 to 67% for RASSF1A given that of VHL (none) was not considered. Interestingly, CIMP+ was found in 56.7% (34/60) of NSCLC, and in 6.7% (4/60) of paired normal tissues and 0% (0/11) of normal blood samples, respectively; CIMP- was present in 43.3% (26/60) of NSCLC, 93.3% (56/60) of paired normal tissues, and 100% (11/11) of normal blood samples, respectively. The data suggest that CIMP status was significantly associated with NSCLC, paired normal tissues and normal blood samples (P<0.001). In addition, there appeared to be a significant association between CIMP status and survival prognosis of NSCLC (P=0.0166). In the present study, for the first time, we shed light on the presence of chromosome 3p-specific CIMP, which might play an important role in tumorigenesis of NSCLC. SN - 0169-5002 UR - https://www.unboundmedicine.com/medline/citation/18358560/CpG_island_methylator_phenotype_involving_tumor_suppressor_genes_located_on_chromosome_3p_in_non_small_cell_lung_cancer_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0169-5002(08)00064-0 DB - PRIME DP - Unbound Medicine ER -